Current Fungal Infection Reports

, Volume 7, Issue 2, pp 132–137

The Role of Human IL-17 Immunity in Fungal Disease

  • László Maródi
  • Sophie Cypowyj
  • Jean-Laurent Casanova
  • Anne Puel
Translational Research (R Wheeler, Section Editor)

DOI: 10.1007/s12281-013-0131-4

Cite this article as:
Maródi, L., Cypowyj, S., Casanova, J. et al. Curr Fungal Infect Rep (2013) 7: 132. doi:10.1007/s12281-013-0131-4

Abstract

Candida species are major causes of invasive and mucocutaneous fungal infections. Various recognition pathways and effector mechanisms are involved in triggering intrinsic, innate and adaptive host immune responses to these fungi. Invasive candidiasis may involve almost any internal organ or anatomic site and is a significant cause of morbidity and mortality in immunocompromised individuals, including, in particular, those with primary immunodeficiency disorders (PIDs) affecting phagocytic cells. Other PIDs characterized by an impairment of IL-17 T cell-mediated immunity confer predisposition to mucocutaneous Candida infections, with Candida albicans in particular. We discuss here inborn errors of immunity leading to an impairment of IL-17-mediated host defense and the occurrence of mucocutaneous candidiasis.

Keywords

Th17 cellsCandidaPrimary immunodeficiency disordersMucocutaneous candidiasis

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • László Maródi
    • 1
  • Sophie Cypowyj
    • 2
  • Jean-Laurent Casanova
    • 2
    • 3
    • 4
  • Anne Puel
    • 2
    • 3
    • 4
  1. 1.Department of Infectious and Pediatric ImmunologyUniversity of Debrecen Medical and Health Science CenterDebrecenHungary
  2. 2.St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller BranchRockefeller University Hospital, The Rockefeller UniversityNew YorkUSA
  3. 3.Laboratory of Human Genetics of Infectious Diseases, Necker BranchINSERM U980ParisFrance
  4. 4.Necker Medical SchoolUniversity Paris DescartesParisFrance